News

Mundipharma presents wealth of data for Penthrox®▼(methoxyflurane) at EUSEM Congress, demonstrating superiority compared to standard of care in trauma pain in adults

15 Oct 2019

FOR EUROPEAN MEDICAL AND TRADE MEDIA ONLY

Swissmedic reviewing licence extension for the SGLT2 inhibitor Invokana® (canagliflozin) in fast-track procedure

10 Oct 2019

STRICTLY FOR EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA ONLY

Cidara Therapeutics and Mundipharma Form Strategic Partnership to Develop and Commercialize Rezafungin

3 Sep 2019

Mundipharma Welcomes the New Guidelines from ESC/EASD Recommending First-Line use of Sodium-Glucose Co-transporter-2 Inhibitors for Type 2 Diabetes Patients with Cardiovascular Disease

3 Sep 2019

STRICTLY FOR EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA ONLY

Mundipharma Announces the Licence Extension Submission for Invokana® (canagliflozin) and Vokanamet® (canagliflozin and metformin) to the European Medicines Agency

22 Aug 2019

FOR EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA

Mundipharma announces exclusive license and supply agreement with Prestige Biopharma for Tuznue® (HD201)

2 Jul 2019

FOR EUROPEAN BUSINESS/TRADE MEDIA ONLY

Invokana® (canagliflozin) Significantly Reduced Major Cardiovascular Events and Kidney Failure in Patients with Type 2 Diabetes and Chronic Kidney Disease in New CREDENCE Analysis

11 Jun 2019

STRICTLY FOR EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA ONLY

Mundipharma announces exclusive outsourcing distribution agreement with Egis Pharmaceuticals for Pelmeg▼® in Central and Eastern Europe

13 May 2019

FOR EUROPEAN BUSINESS/TRADE MEDIA ONLY

Invokana® (canagliflozin) Significantly Reduces the Risk of Renal Failure in Patients with Type 2 Diabetes and Chronic Kidney Disease in the Landmark Phase 3 CREDENCE Study

16 Apr 2019

EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA ONLY

Mountain rescue study launches to investigate use of Penthrox® (methoxyflurane) for trauma-related pain in hostile environments

27 Mar 2019

FOR EUROPEAN MEDICAL AND TRADE MEDIA ONLY